IBDEI1H1 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23800,1,3,0)
 ;;=3^Leiomyoma,Uterus,Intramural
 ;;^UTILITY(U,$J,358.3,23800,1,4,0)
 ;;=4^D25.1
 ;;^UTILITY(U,$J,358.3,23800,2)
 ;;=^267641
 ;;^UTILITY(U,$J,358.3,23801,0)
 ;;=D25.0^^82^1032^92
 ;;^UTILITY(U,$J,358.3,23801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23801,1,3,0)
 ;;=3^Leiomyoma,Uterus,Submucous
 ;;^UTILITY(U,$J,358.3,23801,1,4,0)
 ;;=4^D25.0
 ;;^UTILITY(U,$J,358.3,23801,2)
 ;;=^267640
 ;;^UTILITY(U,$J,358.3,23802,0)
 ;;=D25.2^^82^1032^93
 ;;^UTILITY(U,$J,358.3,23802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23802,1,3,0)
 ;;=3^Leiomyoma,Uterus,Subserosal
 ;;^UTILITY(U,$J,358.3,23802,1,4,0)
 ;;=4^D25.2
 ;;^UTILITY(U,$J,358.3,23802,2)
 ;;=^5002080
 ;;^UTILITY(U,$J,358.3,23803,0)
 ;;=D25.9^^82^1032^94
 ;;^UTILITY(U,$J,358.3,23803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23803,1,3,0)
 ;;=3^Leiomyoma,Uterus,Unspec
 ;;^UTILITY(U,$J,358.3,23803,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,23803,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,23804,0)
 ;;=N94.3^^82^1032^118
 ;;^UTILITY(U,$J,358.3,23804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23804,1,3,0)
 ;;=3^Premenstrual Tension Syndrome
 ;;^UTILITY(U,$J,358.3,23804,1,4,0)
 ;;=4^N94.3
 ;;^UTILITY(U,$J,358.3,23804,2)
 ;;=^5015919
 ;;^UTILITY(U,$J,358.3,23805,0)
 ;;=Z11.51^^82^1032^121
 ;;^UTILITY(U,$J,358.3,23805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23805,1,3,0)
 ;;=3^Screening,HPV
 ;;^UTILITY(U,$J,358.3,23805,1,4,0)
 ;;=4^Z11.51
 ;;^UTILITY(U,$J,358.3,23805,2)
 ;;=^5062674
 ;;^UTILITY(U,$J,358.3,23806,0)
 ;;=Z12.4^^82^1032^125
 ;;^UTILITY(U,$J,358.3,23806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23806,1,3,0)
 ;;=3^Screening,malig Neop,Cervix (Pap)
 ;;^UTILITY(U,$J,358.3,23806,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,23806,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,23807,0)
 ;;=Z12.73^^82^1032^122
 ;;^UTILITY(U,$J,358.3,23807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23807,1,3,0)
 ;;=3^Screening,Malig Neop,Ovary
 ;;^UTILITY(U,$J,358.3,23807,1,4,0)
 ;;=4^Z12.73
 ;;^UTILITY(U,$J,358.3,23807,2)
 ;;=^5062692
 ;;^UTILITY(U,$J,358.3,23808,0)
 ;;=N84.0^^82^1032^127
 ;;^UTILITY(U,$J,358.3,23808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23808,1,3,0)
 ;;=3^Uterine Polyps
 ;;^UTILITY(U,$J,358.3,23808,1,4,0)
 ;;=4^N84.0
 ;;^UTILITY(U,$J,358.3,23808,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,23809,0)
 ;;=N83.02^^82^1032^52
 ;;^UTILITY(U,$J,358.3,23809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23809,1,3,0)
 ;;=3^Cyst,Follicular,Ovary,Left
 ;;^UTILITY(U,$J,358.3,23809,1,4,0)
 ;;=4^N83.02
 ;;^UTILITY(U,$J,358.3,23809,2)
 ;;=^5138940
 ;;^UTILITY(U,$J,358.3,23810,0)
 ;;=N83.01^^82^1032^53
 ;;^UTILITY(U,$J,358.3,23810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23810,1,3,0)
 ;;=3^Cyst,Follicular,Ovary,Right
 ;;^UTILITY(U,$J,358.3,23810,1,4,0)
 ;;=4^N83.01
 ;;^UTILITY(U,$J,358.3,23810,2)
 ;;=^5138939
 ;;^UTILITY(U,$J,358.3,23811,0)
 ;;=N94.12^^82^1032^63
 ;;^UTILITY(U,$J,358.3,23811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23811,1,3,0)
 ;;=3^Dyspareunia,Deep
 ;;^UTILITY(U,$J,358.3,23811,1,4,0)
 ;;=4^N94.12
 ;;^UTILITY(U,$J,358.3,23811,2)
 ;;=^5138974
 ;;^UTILITY(U,$J,358.3,23812,0)
 ;;=N94.19^^82^1032^64
 ;;^UTILITY(U,$J,358.3,23812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23812,1,3,0)
 ;;=3^Dyspareunia,Oth Spec
 ;;^UTILITY(U,$J,358.3,23812,1,4,0)
 ;;=4^N94.19
